Skip to content
Find Clinical Trials
Find Clinical Trials

Effect of agomelatine (25 mg) given orally once a day for 7 days on cerebral activity measured by functional MRI during processing of emotional stimuli in patients with Major Depressive Disorder. A randomised, double-blind, placebo-controlled study with an open extension period of 6 months with agomelatine (25 mg).Comparison to functional MRI profiles of healthy volunteers.

Servier Protocol Code: CL2-20098-067 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2007-005564-27

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00

Results
Interventions / Treatments
  • Major Depressive Disorder
  • AGOMELATINE
  • S020098
Other study id numbers
  • CL2-20098-067